|
DAP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.196790E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.698300E-03 |
| Normal-vs-Stage2 |
2.909400E-01 |
| Normal-vs-Stage3 |
5.724500E-03 |
| Normal-vs-Stage4 |
1.631900E-02 |
| Stage1-vs-Stage2 |
5.942800E-01 |
| Stage1-vs-Stage3 |
3.043800E-01 |
| Stage1-vs-Stage4 |
2.625200E-01 |
| Stage2-vs-Stage3 |
2.739200E-01 |
| Stage2-vs-Stage4 |
2.059600E-01 |
| Stage3-vs-Stage4 |
7.346200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.823900E-03 |
| Normal-vs-AfricanAmerican |
1.776930E-04 |
| Normal-vs-Asian |
3.616400E-01 |
| Caucasian-vs-AfricanAmerican |
5.559200E-03 |
| Caucasian-vs-Asian |
2.267600E-01 |
| AfricanAmerican-vs-Asian |
7.210500E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.985720E-02 |
| Normal-vs-Female |
1.720990E-03 |
| Male-vs-Female |
9.792800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.960200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.316000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.140100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.463000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.920400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.290600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.785200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.019700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.677000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.014400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.907600E-01 |
| Classical-VS-Follicular |
1.828430E-04 |
| Classical-VS-Other |
5.355200E-01 |
| Classical-VS-Normal |
3.55819999999785E-05 |
| Tall-VS-Follicular |
2.504500E-02 |
| Tall-VS-Other |
5.419200E-01 |
| Tall-VS-Normal |
3.083900E-02 |
| Follicular-VS-Other |
5.651400E-01 |
| Follicular-VS-Normal |
7.525600E-01 |
| Other-VS-Normal |
6.827000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.454000E-01 |
| Normal-vs-N1 |
4.779000E-01 |
| N0-vs-N1 |
8.698200E-01 |
|
|
